Zobrazeno 1 - 10
of 2 468
pro vyhledávání: '"Lastra R"'
Autor:
Rodriguez, Esperanza Nancy Pulido1 enpulidor@udistrital.edu.co
Publikováno v:
Ciencia en Desarrollo. 2017 Supplement, Vol. 8, p234-235. 2p.
Autor:
Storozuk T; Department of Pathology, University of Chicago, Chicago, Illinois, USA., Biernacka A; Department of Pathology, University of Chicago, Chicago, Illinois, USA., Lastra R; Department of Pathology, University of Chicago, Chicago, Illinois, USA., Mueller J; Department of Pathology, University of Chicago, Chicago, Illinois, USA., Olivas A; Department of Pathology, University of Chicago, Chicago, Illinois, USA., Reeves W; Department of Pathology, University of Chicago, Chicago, Illinois, USA., Yassan L; Department of Pathology, University of Chicago, Chicago, Illinois, USA., Antic T; Department of Pathology, University of Chicago, Chicago, Illinois, USA.
Publikováno v:
Diagnostic cytopathology [Diagn Cytopathol] 2024 Dec; Vol. 52 (12), pp. 709-714. Date of Electronic Publication: 2024 Jul 25.
Autor:
Sesma A; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Pardo J; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), 28029 Madrid, Spain.; Microbiology, Radiology, Pediatry and Public Health Department Medicine, University of Zaragoza, 50009 Zaragoza, Spain., Isla D; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., M Gálvez E; CIBER de Enfermedades Infecciosas (CIBERINFEC), 28029 Madrid, Spain.; Instituto de Carboquímica (ICB-CSIC), Miguel Luesma 4, 50018 Zaragoza, Spain., Gascón-Ruiz M; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Martínez-Lostao L; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain.; Department of Microbiology, Pediatrics, Radiology and Public Health, University of Zaragoza, 50009 Zaragoza, Spain.; Aragon Nanoscience Institute, 50018 Zaragoza, Spain.; Aragon Materials Science Institute, 50009 Zaragoza, Spain.; Immunology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain., Moratiel A; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Paño-Pardo JR; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), 28029 Madrid, Spain.; Infectious Disease Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain., Quílez E; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Torres-Ramón I; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Yubero A; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Zapata-García M; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Domingo MP; Immunology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain., Esteban P; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Sanz Pamplona R; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Lastra R; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Ramírez-Labrada A; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), 28029 Madrid, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Aug 08; Vol. 16 (16). Date of Electronic Publication: 2024 Aug 08.
Autor:
Zapata-García M; Medical Oncology Department, Lozano Blesa University Hospital Clinic, 50009, Zaragoza, Spain.; Health Research Institute of Aragón (IIS Aragón), 50009, Zaragoza, Spain., Moratiel-Pellitero A; Medical Oncology Department, Lozano Blesa University Hospital Clinic, 50009, Zaragoza, Spain., Isla D; Medical Oncology Department, Lozano Blesa University Hospital Clinic, 50009, Zaragoza, Spain.; Health Research Institute of Aragón (IIS Aragón), 50009, Zaragoza, Spain., Gálvez E; Institute of Carbochemistry (ICB-CSIC), Zaragoza, Spain.; Center for Biomedical Research in the Network of Infectious Diseases (CIBERINFEC), Carlos III Health Institute (ISCIII), Madrid, Spain., Gascón-Ruiz M; Health Research Institute of Aragón (IIS Aragón), 50009, Zaragoza, Spain.; Medical Oncology Department, Miguel Servet University Hospital, 50009, Zaragoza, Spain., Sesma A; Health Research Institute of Aragón (IIS Aragón), 50009, Zaragoza, Spain.; Medical Oncology Department, Miguel Servet University Hospital, 50009, Zaragoza, Spain., Barbero R; Microbiology Department, Ramón y Cajal University Hospital and IRYCIS, Madrid, Spain., Galeano J; Complex Systems Group, Universidad Politécnica de Madrid, Madrid, Spain., Del Campo R; Center for Biomedical Research in the Network of Infectious Diseases (CIBERINFEC), Carlos III Health Institute (ISCIII), Madrid, Spain.; Microbiology Department, Ramón y Cajal University Hospital and IRYCIS, Madrid, Spain., Ocáriz M; Medical Oncology Department, Lozano Blesa University Hospital Clinic, 50009, Zaragoza, Spain., Quílez E; Medical Oncology Department, Lozano Blesa University Hospital Clinic, 50009, Zaragoza, Spain.; Health Research Institute of Aragón (IIS Aragón), 50009, Zaragoza, Spain., Cruellas M; Medical Oncology Department, Vall d'Hebrón University Hospital, 08035, Barcelona, Spain., Remírez-Labrada A; Health Research Institute of Aragón (IIS Aragón), 50009, Zaragoza, Spain., Pardo J; Health Research Institute of Aragón (IIS Aragón), 50009, Zaragoza, Spain.; Center for Biomedical Research in the Network of Infectious Diseases (CIBERINFEC), Carlos III Health Institute (ISCIII), Madrid, Spain.; Microbiology Department, Preventive Medicine and Public Health, University of Zaragoza, 50009, Zaragoza, Spain., Martínez-Lostao L; Microbiology Department, Preventive Medicine and Public Health, University of Zaragoza, 50009, Zaragoza, Spain., Domingo MP; Institute of Carbochemistry (ICB-CSIC), Zaragoza, Spain., Esteban P; Health Research Institute of Aragón (IIS Aragón), 50009, Zaragoza, Spain., Torres-Ramón I; Medical Oncology Department, Lozano Blesa University Hospital Clinic, 50009, Zaragoza, Spain.; Health Research Institute of Aragón (IIS Aragón), 50009, Zaragoza, Spain., Yubero A; Medical Oncology Department, Lozano Blesa University Hospital Clinic, 50009, Zaragoza, Spain.; Health Research Institute of Aragón (IIS Aragón), 50009, Zaragoza, Spain., Paño JR; Health Research Institute of Aragón (IIS Aragón), 50009, Zaragoza, Spain.; ESCMID Fellow, Infectious Diseases Department, Lozano Blesa University Hospital Clinic, Zaragoza, Spain and University of Zaragoza, 50009, Zaragoza, Spain., Lastra R; Medical Oncology Department, Lozano Blesa University Hospital Clinic, 50009, Zaragoza, Spain.; Health Research Institute of Aragón (IIS Aragón), 50009, Zaragoza, Spain.
Publikováno v:
Heliyon [Heliyon] 2024 Jul 01; Vol. 10 (13), pp. e33684. Date of Electronic Publication: 2024 Jul 01 (Print Publication: 2024).
Autor:
Lucas-Guerra C; Facultad de Enfermería, Fisioterapia y Podología, Universidad Complutense de Madrid; Facultad de Salud de la Universidad Camilo José Cela; Madrid, Spain. Electronic address: claraluc@ucm.es., González-Ordi H; Departamento de Psicología Experimental, Procesos Cognitivos y Logopedia, Facultad de Enfermería, Fisioterapia y Podología, Universidad Complutense de Madrid, Madrid, Spain., Del-Gallego-Lastra R; Departamento de Enfermería, Facultad de Enfermería, Fisioterapia y Podología, Universidad Complutense de Madrid, Madrid, Spain.
Publikováno v:
Enfermeria clinica (English Edition) [Enferm Clin (Engl Ed)] 2024 Jul-Aug; Vol. 34 (4), pp. 271-292. Date of Electronic Publication: 2024 Jul 20.
Autor:
Taya M; Division of Hematology and Oncology, UT Southwestern, Dallas, TX, USA., Hou X; Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA., Veneris JT; Department of Medicine, Section of Hematology and Oncology, The University of Chicago, Chicago, IL, USA., Kazi N; Division of Hematology and Oncology, UT Southwestern, Dallas, TX, USA., Larson MC; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Maurer MJ; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Heinzen EP; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA., Chen H; Department of Pathology, UT Southwestern, Dallas, TX, USA., Lastra R; Department of Pathology, The University of Chicago, Chicago, IL, USA., Oberg AL; Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Weroha SJ; Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA., Fleming GF; Department of Medicine, Section of Hematology and Oncology, The University of Chicago, Chicago, IL, USA., Conzen SD; Division of Hematology and Oncology, UT Southwestern, Dallas, TX, USA. suzanne.conzen@utsouthwestern.edu.
Publikováno v:
Journal of gynecologic oncology [J Gynecol Oncol] 2024 Jun 14. Date of Electronic Publication: 2024 Jun 14.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Moratiel-Pellitero A; Medical Oncology Department, University Hospital Lozano Blesa, Institute for Health Research Aragón, 50009 Zaragoza, Spain., Zapata-García M; Medical Oncology Department, University Hospital Lozano Blesa, Institute for Health Research Aragón, 50009 Zaragoza, Spain., Gascón-Ruiz M; Medical Oncology Department, Miguel Servet University Hospital, 50009 Zaragoza, Spain., Sesma A; Medical Oncology Department, Miguel Servet University Hospital, 50009 Zaragoza, Spain., Quílez E; Medical Oncology Department, University Hospital Lozano Blesa, Institute for Health Research Aragón, 50009 Zaragoza, Spain., Ramirez-Labrada A; Aragon Health Research Institute, 50018 Zaragoza, Spain.; Center for Biomedical Research in the Network of Infectious Diseases (CIBERINFEC), Carlos III Health Institute (ISCIII), 28040 Madrid, Spain., Martínez-Lostao L; Aragon Health Research Institute, 50018 Zaragoza, Spain.; Microbiology Department, Preventive Medicine and Public Health, University of Zaragoza, 50009 Zaragoza, Spain., Domingo MP; Institute of Carbochemistry (ICB-CSIC), 50018 Zaragoza, Spain., Esteban P; Aragon Health Research Institute, 50018 Zaragoza, Spain., Yubero A; Medical Oncology Department, University Hospital Lozano Blesa, Institute for Health Research Aragón, 50009 Zaragoza, Spain., Barbero-Herranz R; Microbiology Department, University Hospital Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain., Moreno-Blanco A; Center for Biomedical Research in the Network of Infectious Diseases (CIBERINFEC), Carlos III Health Institute (ISCIII), 28040 Madrid, Spain.; Microbiology Department, University Hospital Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain., Paño JR; Center for Biomedical Research in the Network of Infectious Diseases (CIBERINFEC), Carlos III Health Institute (ISCIII), 28040 Madrid, Spain.; Infectious Diseases Department, Lozano Blesa University Hospital Clinic, Institute for Health Research Aragón, University of Zaragoza, 50009 Zaragoza, Spain., Lastra R; Medical Oncology Department, University Hospital Lozano Blesa, Institute for Health Research Aragón, 50009 Zaragoza, Spain., Pardo J; Aragon Health Research Institute, 50018 Zaragoza, Spain.; Center for Biomedical Research in the Network of Infectious Diseases (CIBERINFEC), Carlos III Health Institute (ISCIII), 28040 Madrid, Spain.; Microbiology Department, Preventive Medicine and Public Health, University of Zaragoza, 50009 Zaragoza, Spain., Isla D; Medical Oncology Department, University Hospital Lozano Blesa, Institute for Health Research Aragón, 50009 Zaragoza, Spain., Del Campo R; Center for Biomedical Research in the Network of Infectious Diseases (CIBERINFEC), Carlos III Health Institute (ISCIII), 28040 Madrid, Spain.; Microbiology Department, University Hospital Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.; Facultad de Ciencias de la Salud, Universidad Alfonso X El Sabio, 28691 Villanueva de la Cañada, Spain., Gálvez E; Center for Biomedical Research in the Network of Infectious Diseases (CIBERINFEC), Carlos III Health Institute (ISCIII), 28040 Madrid, Spain.; Institute of Carbochemistry (ICB-CSIC), 50018 Zaragoza, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Mar 13; Vol. 16 (6). Date of Electronic Publication: 2024 Mar 13.